Drug
Rdn 929
Rdn 929: highest development phase Phase 1, developed by Alkermes. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Alkermes
Trials
| Drug | Phase | Indication |
|---|---|---|
| RDN-929 NCT03668314 | Phase 1 | Healthy |
| RDN-929 oral capsule NCT03963973 | Phase 1 | Healthy |
Latest
No recent events.
Follow Rdn 929 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.